Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
COVID-19 convalescent plasma (1 trial)
loratadine (claritin) (1 trial)
montelukast (singulair) (1 trial)
artemisia (1 trial)
camostat mesylate (1 trial)
cranberry (2 trials)
lactobacillus plantarum (1 trial)
lactobacillus reuteri (5 trials)
omega-5 fatty acids (1 trial)
Pediococcus acidilactici (1 trial)
vitis vinifera (1 trial)
Asthma (Phase 3)
Hypertension (Phase 2)
Trials (11 total)
Trial APIs (11 total)